Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19891
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: *Adenocarcinoma/drug therapy/mortality/secondary,Adult,Aged,Antineoplastic Combined Chemotherapy Protocols/administration & dosage/adverse,effects/*therapeutic use,Camptothecin/administration & dosage/adverse effects/analogs &,derivatives/therapeutic use,Disease-Free Survival,Drug Administration Schedule,Female,Humans,Male,Middle Aged,Neoplasms, Unknown Primary/*drug therapy/mortality,Organoplatinum Compounds/administration & dosage/adverse effects/therapeutic use
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/19891
ISSN: 0344-5704
Link: http://www.ncbi.nlm.nih.gov/pubmed/17901952
http://www.springerlink.com/content/n82v1wj2u2l46925/fulltext.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Briasoulis-2008-Multicenter phase-II.pdf329.17 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons